Navigation Links
Conventional, annual Pap smear cost-effective follow-up after cervical lesion treatment
Date:10/20/2010

(SACRAMENTO, Calif.) A study of the options for reducing cancer incidence and mortality among women who have been treated for precancerous cervical lesions found that an annual conventional Pap smear is a cost effective strategy.

Joy Melnikow, professor in the Department of Family and Community Medicine and colleagues tested several follow-up screening strategies for the 500,000 American women diagnosed and treated for cervical intraepithelial neoplasia (CIN), abnormal cervical cell growth that can lead to cervical cancer. The first comprehensive study of its kind, "Surveillance After Treatment for Cervical Intraepithelial Neoplasia" will be published in the November issue of Obstetrics & Gynecology.

"This is a large and growing pool of women who need follow-up after treatment," said Melnikow, who is also director of the UC Davis Center for Healthcare Policy and Research. "But we've had few studies on which to base recommendations for follow-up."

Detection and treatment of these pre-cancerous lesions have led to large reductions in cervical cancer incidence and death in many countries where screening is routine. But current recommendations about follow-up over time vary widely, and the use of newer technologies had not been fully evaluated until now, Melnikow said.

Melnikow and her colleagues examined the relative benefits and costs for different strategies, including the frequency of follow-up testing. "What we learned was that the newer technologies such as liquid-based Pap testing and HPV (human papillomavirus ) testing add considerable cost but little to no benefit compared with conventional Pap smear follow-up," she said.

Among the options currently in use for women who have undergone treatment for CIN are conventional cervical cytology (Pap test) at six and 12 months followed by routine Pap testing if these tests are negative. Some patients are given colposcopy (an examination of the cervix using a m
'/>"/>

Contact: Dorsey Griffith
dorsey.griffith@ucdmc.ucdavis.edu
916-734-9118
University of California -- Davis - Health System
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Pet Dental Month Prime Time To Schedule Preventive Annual Cleaning For Pets
2. AAPC to Host 18th Annual National Conference in Nashville
3. Firmex Achieves 237% Annual Revenue Growth Despite Tough M&A Environment in 2009
4. MIT's Center for Transportation & Logistics Announces new Environmental Performance Consortium at Annual Crossroads Conference
5. Tyco International to Host 2010 Annual General Meeting of Shareholders
6. Heska Announces Q4 and Annual 2009 Results
7. Aflac Incorporated to Present at the 35th Annual Association of Insurance and Financial Analysts (AIFA) Conference
8. The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite N Day Festival Celebrates the Year of the Tiger This Weekend
9. Restaurants, C-Stores and Retailers Defy the Challenging Economy Raising A Record $5.6 Million During Annual St. Jude Halloween Promotion
10. NIAID media tip sheet: Annual Meeting of the American Academy of Allergy, Asthma and Immunology
11. National Patient Advocate Foundation Delivers Constituent Cases to White House Health Summit Participants to Urge Elimination of Pre-Existing Conditions, Annual/Lifetime Limits and Capping Out-of-Pocket Expenses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... In honor of National Health IT Week ... IT professionals for gaining a competitive edge in the ... shows demand for qualified health IT professionals are at ... the differentiating factor when filling a position. The skill ... has clinical workflow and terminology experience. American Sentinel offers ...
(Date:9/17/2014)... CA / MANILA, PHILIPPINES (PRWEB) September 17, 2014 ... providing Managed Operations and Business Process Outsourcing (BPO) services ... joined the firm as the Senior Vice President – ... U.S.. , Cary Weltken is a 15 year ... a wealth of experience in helping companies, ranging in ...
(Date:9/17/2014)... 17, 2014 Health.Verticalize, a healthcare marketing ... their health insurance options in the 2014 open enrollment ... , Moving forward Health Network will be ... company has intentionally remained out of the spotlight for ... a single website to its present position with dozens ...
(Date:9/17/2014)... September 17, 2014 1st-Dress.com, one of ... range of long bridesmaid dresses recently. All ... with top quality materials. Furthermore, they are offered at ... percent off. , The firm is striving to ... More importantly, its workers never compromises on style, quality ...
(Date:9/16/2014)... 2014 Top10BestSEOHosting.com has recently compared ... recommended companies for the webmasters that want to ... , The senior spokesman for Top10BestSEOHosting.com says, ... and HostMonster are the excellent hosting companies for ... a wide range of advanced features while still ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:MicroSourcing Appoints New Senior Vice President of North America 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 3Health News:2014 Long Bridesmaid Dresses Available Online At 1st-Dress.com 2Health News:Top10BestSEOHosting.com: Arvixe Is One Of The Best SEO Hosting Suppliers 2
... DENVER, July 31 Birner Dental Management,Services, Inc. ... dental practices,will conduct a conference call to review ... results, the teleconference may include,discussion of management,s expectations ... be held on Thursday, August 14, 2008 at ...
... 9% Increase In Revenues - - Florida Upholds Contract Award To Orchid ... ... - Regional Tender Work Underway In U.K. -, PRINCETON, N.J., ... identity DNA testing,services, today reported its financial results for the second quarter of,2008., ...
... Fla., July 31 NeoGenomics, Inc.,(OTC Bulletin Board: NGNM) today ... during the quarter included,the following:, Second Quarter 2008 ... 07 -- 17% sequential increase in revenue vs. Q1 ... initiative -- Average number of tests/requisition ...
... safety services, gained four new contracts in the second quarter, including ... awarded a significant contract expansion. , ... Little Falls, ... http://www.sentrx.com/drug_safety_services.shtml [drug safety __title__ drug safety] services, announced today ...
... QHR hospital client King,s Daughters Medical Center (KDMC) in ... grant as a part of the 2009 Health and ... by the Senate Appropriations Committee earlier this month. KDMC,s ... Wicker (Miss.), was initiated by QHR and its strategic ...
... The bestselling guide is now filled with new, essential information for knowing ... treatable disease. , ... Hoboken, NJ (PRWEB) July 31, 2008 -- Ever ... the book has been a major resource for those with diabetes and ...
Cached Medicine News:Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 2Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 3Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 4Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 5Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 6Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 7Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 8Health News:Orchid Cellmark Reports Second Quarter 2008 Financial Results 9Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 2Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 3Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 4Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 5Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 6Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 7Health News:NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008 8Health News:Sentrx Growth Continues with Four New Clients in Second Quarter 2Health News:Sentrx Growth Continues with Four New Clients in Second Quarter 3Health News:Healthcare Consulting Leader QHR, Strategic Health Care, Sen. Roger Wicker Partnership Yields $500,000 Grant for King's Daughters Medical Center 2Health News:Healthcare Consulting Leader QHR, Strategic Health Care, Sen. Roger Wicker Partnership Yields $500,000 Grant for King's Daughters Medical Center 3Health News:Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field 2Health News:Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field 3Health News:Diabetes For Dummies, 3rd Edition, Reports on the Latest Developments in the Field 4
(Date:9/16/2014)... 3SBio Inc., ("3SBio") a leading biotechnology ... focusing on researching, developing, manufacturing and marketing biopharmaceutical ... an exclusive license agreement with JenKem Technology Co., ... in Mainland China of PEG-irinotecan, a long-acting polymer-drug ... over-expressed in many solid tumors, including colorectal, ovarian, ...
(Date:9/16/2014)... OAKLAND, Calif. , Sept. 16, 2014  Chairman ... that Richard (Dick) Daniels will assume the ... Foundation Hospitals and Health Plan, Inc., effective immediately. ... developing and implementing technological advancements that advance the high-quality ... members," Tyson said. " Dick Daniels has extensive ...
(Date:9/16/2014)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) ... all of the outstanding shares of Auxilium Pharmaceuticals, Inc. (NASDAQ: ... $28.10 in a cash and stock transaction valued at $2.2 ... to Auxilium,s closing price on September 16, 2014 and a ... for the previous 30 days.  Under the terms of the ...
Breaking Medicine Technology:3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Name Interim Chief Information Officer 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 3Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 4Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 5Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 6Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 7
... KineMed Inc., a,pathway-based drug discovery and development ... of an investigational agent,to regenerate nerve cells in ... cognition and mood. The agent, part of a ... a behavioral test in a,preclinical model. The findings ...
... am ET, BEDMINSTER, N.J., Oct. 11 ... top-line results from,the company,s Phase 3 study of ... 83 patients with short bowel,syndrome (SBS) received either ... dose (0.10 mg/kg/day) or placebo. The,clinical efficacy endpoint ...
Cached Medicine Technology:KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 2KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 2Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 4Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 5Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 6Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 7
... These offer truly exceptional quality for this ... aberration has been dramatically improved with performance ... These objectives are also corrected for spherical ... entire 22mm field of view. The DL ...
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark...
... Designed for the scientist who wants ... the TE2000E2 is a high precision Z-focus ... This makes it possible to expand ... sources and image outputs. A five-way ...
... The IX71's modular ... provides 9 access ports ... output devices. Up to ... simultaneous access to a ...
Medicine Products: